Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Chordia Therapeutics Inc. ( (JP:190A) ) is now available.
Chordia Therapeutics Inc. announced a change in its major shareholder, as Innovation Kyoto 2016 Investment Limited Liability Partnership reduced its voting rights from 10.14% to 9.99% due to the sale of common stock. This change is not expected to impact the company’s management or business performance.
More about Chordia Therapeutics Inc.
Chordia Therapeutics Inc. is a company operating in the pharmaceutical industry, focusing on the development of innovative therapies. The company is based in Fujisawa City, Kanagawa Prefecture, Japan, and is led by Chief Executive Officer Hiroshi Miyake.
Average Trading Volume: 874,392
Technical Sentiment Signal: Strong Sell
See more insights into 190A stock on TipRanks’ Stock Analysis page.